The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Zygomatic implants represent one of the most significant advances in treatment options for seniors with severe maxillary bone loss.

Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% and total abscess clearance in 22%–62% of participants. Phase 3 data show ...

Innovaccer Inc., a leading healthcare AI company, today announced that Beckman Coulter Diagnostics, a global clinical diagnostics leader and a Danaher company, has selected Gravity, Innovaccer’s ...

The partnership connects structured clinical data with EHR workflows to accelerate referrals, care coordination, and ...

This article is part of our series on clinical data considerations. Read How to Prepare for Disclosure. For publicly traded biotech companies, disclosing clinical trial data can be an exciting ...

Healthcare providers receive data from many disparate sources: hospitals, doctors’ offices, labs and lab machines, medical devices, pharmacies, and more. Investment in the correct infrastructure to ...

As a CMS-approved QCDR, OneOncology is authorized to collect clinical data from a variety of sources and report MIPS measures for partner practices and their clinicians across all of their EMR ...

Jasper Therapeutics, Inc. announced that it is presenting updated clinical data from its Phase 1b/2a BEACON study on briquilimab, an antibody therapy targeting c-Kit to treat mast cell-driven diseases ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

This program celebrates those who drive innovation, efficiency and excellence across the healthcare industry. By acknowledging the leading innovators within the industry, Modern Healthcare aims to ...

This article is part of our series on clinical data considerations. Read How to Approach Fundraising and Investor Relations. When it comes to disclosing clinical trial data in the biotechnology arena, ...